Abstract
Discusses the circumstances in which a European patent may be refused for a biotechnological invention because of concern about the morality of the invention, focusing on the meaning of commercial exploitation in this context. Reviews case law, considering whether the research methods used to develop the invention, the potential use of the invention, and the exclusivity and monopoly which the applicant seeks may be subject to scrutiny.
| Original language | English |
|---|---|
| Pages (from-to) | 193-212 |
| Journal | Intellectual Property Quarterly |
| Volume | 2 |
| Publication status | Published - 2008 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Morally Regulating Innovation: What is 'Commercial Exploitation'?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver